Phase I Study of GSK1550188 in Japanese Subjects With Systemic Lupus Erythematosus (SLE)
Status:
Completed
Trial end date:
2010-11-27
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK) and
pharmacodynamics (PD) of GSK1550188 in Japanese subjects with Systemic Lupus Erythematosus
(SLE).